Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Weight-loss drugs reduce kidney complication risks: Study

by
May 24, 2024
in Health Care
0
Weight-loss drugs reduce kidney complication risks: Study

The active ingredient in Ozempic and Wegovy may help reduce the risk of kidney failure in those with Type 2 diabetes and chronic kidney disease, according to a study published in the New England Journal of Medicine.

Researchers across 28 countries randomly assigned patients with Type 2 diabetes and chronic kidney disease to receive a weekly injection of 1 milligram of semaglutide, the active ingredient in Ozempic, or a placebo. Roughly 3,500 patients participated in the study, with half receiving semaglutide and the other half a placebo.

The study, which began in 2019, was funded by Novo Nordisk, which manufactures semaglutide.

In follow-ups among participants, the risk of a kidney disease events was found to be 24 percent lower in the semaglutide group than the placebo group.

“Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease,” researchers concluded.

Novo Nordisk announced in October it was halting its trial on kidney outcomes early due to already meeting “certain pre-specified criteria.”

According to the National Institute of Diabetes and Digestive and Kidney Diseases, diabetes is the leading cause of kidney disease, with 1 in 3 diabetics having the condition. About 12 percent of the U.S. population is estimated to have diabetes.

In the U.S., semaglutide is approved for treating Type 2 diabetes and obesity and for reducing the risk of major cardiovascular events. The latter is the most recent, with federal regulators granting the approval based on the results of a multinational study also funded by Novo Nordisk earlier this year.

Other GLP-1 agonists similar to Ozempic are similarly being tested to see if they may be able to treat conditions other than diabetes and obesity. Tirzepatide, sold under the name Mounjaro by Eli Lilly, is currently being studied for any potential benefits in treating chronic kidney disease in patients with obesity with or without Type 2 diabetes.

Previous studies have indicated GLP-1 agonists may be able to help with other conditions like addiction and reducing the risk of dementia.

Previous Post

Democrats see Supreme Court crisis in second Alito flag controversy

Next Post

Sparks fly over SNAP at contentious markup of House farm bill

Next Post
Sparks fly over SNAP at contentious markup of House farm bill

Sparks fly over SNAP at contentious markup of House farm bill

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    What to know about RFK Jr.’s effort to link Tylenol and autism

    What to know about RFK Jr.’s effort to link Tylenol and autism

    September 22, 2025
    Spanberger hits Earle-Sears over health care, education in new ad

    Spanberger hits Earle-Sears over health care, education in new ad

    September 22, 2025
    Trump administration halts government hunger report

    Trump administration halts government hunger report

    September 22, 2025

    Trending

    Study finds rare vision issues in taking GLP-1 weight loss drugs

    Study finds rare vision issues in taking GLP-1 weight loss drugs

    February 12, 2025
    Trump celebrates pardons of anti-abortion activists at March for Life 

    Trump celebrates pardons of anti-abortion activists at March for Life 

    January 24, 2025
    FDA took 15 months to act on infant formula whistleblower complaint, audit says

    FDA took 15 months to act on infant formula whistleblower complaint, audit says

    June 17, 2024
    Health officials prepare for measles spread as disinformation threatens already low vaccination rates

    Health officials prepare for measles spread as disinformation threatens already low vaccination rates

    March 15, 2025

    Recent News

    What to know about RFK Jr.’s effort to link Tylenol and autism

    What to know about RFK Jr.’s effort to link Tylenol and autism

    September 22, 2025
    Spanberger hits Earle-Sears over health care, education in new ad

    Spanberger hits Earle-Sears over health care, education in new ad

    September 22, 2025

    Popular News

    • What to know about RFK Jr.’s effort to link Tylenol and autism
    • Spanberger hits Earle-Sears over health care, education in new ad

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.